Gayatri Bioorganics resubmits audited FY2026 results to BSE to correct typographical errors in original filing.
Company reports FY2026 net loss of ₹111.18 lakhs with negative equity of ₹(3,700.49) lakhs.
Auditors issue unmodified opinion, noting company relies on promoter comfort letter for going concern.
Disclosure reveals multiple material legal disputes totaling ₹24.85 crore in contingent liabilities.